Mitochondria in HIV-1-induced apoptosis

Biochemical and Biophysical Research Communications

Volumn 304, Issue 3, 2003, Pages 561-574

  Arnoult, Damien ^a,c   Petit, Frédéric ^a   Lelièvre, Jean Daniel ^a   Estaquier, Jérôme ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT PASTEUR   (France)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CASPASE INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; CYCLIN B; CYTOCHROME C; FAS ANTIGEN; INDINAVIR; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS ENVELOPE PROTEIN; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; BONE MARROW TOXICITY; BYSTANDER EFFECT; CELL DEATH; CELL MEMBRANE POTENTIAL; DRUG BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LACTIC ACIDEMIA; LIVER TOXICITY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; MYOPATHY; NEUROPATHY; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RETROVIRUS INFECTION; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037427473     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00629-6     Document Type: Article

References (190)

1. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
2. Ameisen J.C., Estaquier J., Idziorek T. From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol. Rev. 142:1994;9-51.
3. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
4. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
5. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
6. Clerici M., Stocks N.I., Zajac R.A., Boswell R.N., Lucey D.R., Via C.S., Shearer G.M. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84:1989;1892-1899.
7. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
8. Sarin A., Clerici M., Blatt S.P., Hendrix C.W., Shearer G.M., Henkart P.A. Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J. Immunol. 153:1994;862-872.
9. Gougeon M.L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C., Montagnier L. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses. 9:1993;553-563.
10. Oyaizu N., McCloskey T.W., Coronesi M., Chirmule N., Kalyanaraman V.S., Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82:1993;3392-3400.
11. Clerici M., Sarin A., Coffman R.L., Wynn T.A., Blatt S.P., Hendrix C.W., Wolf S.F., Shearer G.M., Henkart P.A. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA. 91:1994;11811-11815.
12. Estaquier J., Idziorek T., de Bels F., Barre-Sinoussi F., Hurtrel B., Aubertin A.M., Venet A., Mehtali M., Muchmore E., Michel P.et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA. 91:1994;9431-9435.
13. Lewis D.E., Tang D.S., Adu-Oppong A., Schober W., Rodgers J.R. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol. 153:1994;412-420.
14. Muro-Cacho C.A., Pantaleo G., Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566.
15. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., Baba T.W., Ruprecht R.M., Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes [see comments]. Nat. Med. 1:1995;129-134.
16. Davis I.C., Girard M., Fultz P.N. Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J. Virol. 72:1998;4623-4632.
17. del Llano A.M., Amieiro-Puig J.P., Kraiselburd E.N., Kessler M.J., Malaga C.A., Lavergne J.A. The combined assessment of cellular apoptosis, mitochondrial function and proliferative response to pokeweed mitogen has prognostic value in SIV infection. J. Med. Primatol. 22:1993;147-153.
18. Schuitemaker H., Meyaard L., Kootstra N.A., Dubbes R., Otto S.A., Tersmette M., Heeney J.L., Miedema F. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J. Infect. Dis. 168:1993;1140-1147.
19. Novembre F.J., de Rosayro J., Nidtha S., O'Neil S.P., Gibson T.R., Evans-Strickfaden T., Hart C.E., McClure H.M. Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees. J. Virol. 75:2001;1533-1539.
20. Prati E., Gorla R., Malacarne F., Airo P., Brugnoni D., Gargiulo F., Tebaldi A., Castelli F., Carosi G., Cattaneo R. Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res. Hum. Retroviruses. 13:1997;1501-1508.
21. Liegler T.J., Yonemoto W., Elbeik T., Vittinghoff E., Buchbinder S.P., Greene W.C. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J. Infect. Dis. 178:1998;669-679.
22. Chavan S.J., Tamma S.L., Kaplan M., Gersten M., Pahwa S.G. Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy. Clin. Immunol. 93:1999;24-33.
23. Aries S.P., Weyrich K., Schaaf B., Hansen F., Dennin R.H., Dalhoff K. Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1. Scand. J. Immunol. 48:1998;86-91.
24. Badley A.D., Dockrell D.H., Algeciras A., Ziesmer S., Landay A., Lederman M.M., Connick E., Kessler H., Kuritzkes D., Lynch D.H., Roche P., Yagita H., Paya C.V. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102:1998;79-87.
25. Bohler T., Walcher J., Holzl-Wenig G., Geiss M., Buchholz B., Linde R., Debatin K.M. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. Aids. 13:1999;779-789.
26. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2000;2951-2964.
27. Mellors J.W., Rinaldo C.R. Jr., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
28. Laurent-Crawford A.G., Krust B., Muller S., Riviere Y., Rey-Cuille M.A., Bechet J.M., Montagnier L., Hovanessian A.G. The cytopathic effect of HIV is associated with apoptosis. Virology. 185:1991;829-839.
29. Terai C., Kornbluth R.S., Pauza C.D., Richman D.D., Carson D.A. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1991;1710-1715.
30. Laurent-Crawford A.G., Krust B., Riviere Y., Desgranges C., Muller S., Kieny M.P., Dauguet C., Hovanessian A.G. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses. 9:1993;761-773.
31. Laurent-Crawford A.G., Coccia E., Krust B., Hovanessian A.G. Membrane-expressed HIV envelope glycoprotein heterodimer is a powerful inducer of cell death in uninfected CD4+ target cells. Res. Virol. 146:1995;5-17.
32. Corbeil J., Richman D.D. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. J. Gen. Virol. 76:1995;681-690.
33. Corbeil J., Tremblay M., Richman D.D. HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck. J. Exp. Med. 183:1996;39-48.
34. Glynn J.M., McElligott D.L., Mosier D.E. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE- family protease inhibition but not by a Fas(CD95) antagonist. J. Immunol. 157:1996;2754-2758.
35. Gandhi R.T., Chen B.K., Straus S.E., Dale J.K., Lenardo M.J., Baltimore D. HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J. Exp. Med. 187:1998;1113-1122.
36. Moutouh L., Estaquier J., Richman D.D., Corbeil J. Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors. J. Virol. 72:1998;8061-8072.
37. Petit F., Arnoult D., Lelievre J.D., Moutouh-de Parseval L., Hance A.J., Schneider P., Corbeil J., Ameisen J.C., Estaquier J. Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J. Biol. Chem. 277:2002;1477-1487.
38. Katsikis P.D., Garcia-Ojeda M.E., Torres-Roca J.F., Tijoe I.M., Smith C.A., Herzenberg L.A. Interleukin-1β converting enzyme-like protease involvement in Fas- induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation- induced T cell death in HIV infection. J. Exp. Med. 186:1997;1365-1372.
39. Jeremias I., Herr I., Boehler T., Debatin K.M. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28:1998;143-152.
40. Chinnaiyan A.M., Woffendin C., Dixit V.M., Nabel G.J. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nat. Med. 3:1997;333-337.
41. Bolton D.L., Hahn B.I., Park E.A., Lehnhoff L.L., Hornung F., Lenardo M.J. Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J. Virol. 76:2002;5094-5107.
42. Lenardo M.J., Angleman S.B., Bounkeua V., Dimas J., Duvall M.G., Graubard M.B., Hornung F., Selkirk M.C., Speirs C.K., Trageser C., Orenstein J.O., Bolton D.L. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J. Virol. 76:2002;5082-5093.
43. Matsumura H., Shimizu Y., Ohsawa Y., Kawahara A., Uchiyama Y., Nagata S. Necrotic death pathway in fas receptor signaling [In Process Citation]. J. Cell Biol. 151:2000;1247-1256.
44. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.-L., Schneider P., Seed B., Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:2000;489-495.
45. Dumont C., Durrbach A., Bidere N., Rouleau M., Kroemer G., Bernard G., Hirsch F., Charpentier B., Susin S.A., Senik A. Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult. Blood. 96:2000;1030-1038.
46. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor [see comments]. Nature. 397:1999;441-446.
47. Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA. 97:2000;14376-14381.
48. Plymale D.R., Tang D.S., Comardelle A.M., Fermin C.D., Lewis D.E., Garry R.F. Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. Aids. 13:1999;1827-1839.
49. Kolesnitchenko V., Wahl L.M., Tian H., Sunila I., Tani Y., Hartmann D.P., Cossman J., Raffeld M., Orenstein J., Samelson L.E.et al. Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. Proc. Natl. Acad. Sci. USA. 92:1995;11889-11893.
50. Kolesnitchenko V., King L., Riva A., Tani Y., Korsmeyer S.J., Cohen D.I. A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis. J. Virol. 71:1997;9753-9763.
51. Borthwick N.J., Wickremasinghe R.G., Lewin J., Fairbanks L.D., Bofill M. Activation-associated necrosis in human immunodeficiency virus infection. J. Infect. Dis. 179:1999;352-360.
52. LaBonte J.A., Patel T., Hofmann W., Sodroski J. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J. Virol. 74:2000;10690-10698.
53. Genini D., Sheeter D., Rought S., Zaunders J.J., Susin S.A., Kroemer G., Richman D.D., Carson D.A., Corbeil J., Leoni L.M. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 15:2001;5-6.
54. Ferri K.F., Jacotot E., Blanco J., Este J.A., Zamzami N., Susin S.A., Xie Z., Brothers G., Reed J.C., Penninger J.M., Kroemer G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J. Exp. Med. 192:2000;1081-1092.
55. Strack P.R., Frey M.W., Rizzo C.J., Cordova B., George H.J., Meade R., Ho S.P., Corman J., Tritch R., Korant B.D. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA. 93:1996;9571-9576.
56. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1997;1281-1292.
57. Gross A., Jockel J., Wei M.C., Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:1998;3878-3885.
58. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., Korsmeyer S.J., Shore G.C. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143:1998;207-215.
59. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V.M., Adelman D.M., Simon M.C., Ma A., Golden J.A., Evan G., Korsmeyer S.J., MacGregor G.R., Thompson C.B. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
60. Xiang J., Chao D.T., Korsmeyer S.J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559-14563.
61. Banki K., Hutter E., Gonchoroff N.J., Perl A. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 273:1998;11944-11953.
62. Cossarizza A., Mussini C., Mongiardo N., Borghi V., Sabbatini A., De Rienzo B., Franceschi C. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS. 11:1997;19-26.
63. Macho A., Castedo M., Marchetti P., Aguilar J.J., Decaudin D., Zamzami N., Girard P.M., Uriel J., Kroemer G. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood. 86:1995;2481-2487.
64. Reed J.C. Cytochrome c: can't live with it-can't live without it [comment]. Cell. 91:1997;559-562.
65. Castedo M., Macho A., Zamzami N., Hirsch T., Marchetti P., Uriel J., Kroemer G. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:1995;3277-3284.
66. Aries S.P., Schaaf B., Muller C., Dennin R.H., Dalhoff K. Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 73:1995;591-593.
67. Baumler C.B., Bohler T., Herr I., Benner A., Krammer P.H., Debatin K.M. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood. 88:1996;1741-1746.
68. Bohler T., Debatin K.M., Linde R. Sensitivity of CD4+ peripheral blood T cells toward spontaneous and CD95 (APO-1/Fas)-induced apoptosis in pediatric human immunodeficiency virus infection. Blood. 94:1999;1829-1833.
69. Dockrell D.H., Badley A.D., Algeciras-Schimnich A., Simpson M., Schut R., Lynch D.H., Paya C.V. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Res. Hum. Retroviruses. 15:1999;1509-1518.
70. Estaquier J., Idziorek T., Zou W., Emilie D., Farber C.M., Bourez J.M., Ameisen J.C. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1995;1759-1767.
71. Estaquier J., Tanaka M., Suda T., Nagata S., Golstein P., Ameisen J.C. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:1996;4959-4966.
72. Gehri R., Hahn S., Rothen M., Steuerwald M., Nuesch R., Erb P. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS. 10:1996;9-16.
73. Hosaka N., Oyaizu N., Kaplan M.H., Yagita H., Pahwa S. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus- infected persons. J. Infect. Dis. 178:1998;1030-1039.
74. Katsikis P.D., Wunderlich E.S., Smith C.A., Herzenberg L.A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:1995;2029-2036.
75. McCloskey T.W., Oyaizu N., Kaplan M., Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry. 22:1995;111-114.
76. Silvestris F., Cafforio P., Frassanito M.A., Tucci M., Romito A., Nagata S., Dammacco F. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS. 10:1996;131-141.
77. Sloand E.M., Young N.S., Kumar P., Weichold F.F., Sato T., Maciejewski J.P. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood. 89:1997;1357-1363.
78. Algeciras A., Dockrell D.H., Lynch D.H., Paya C.V. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J. Exp. Med. 187:1998;711-720.
79. Badley A.D., Dockrell D., Simpson M., Schut R., Lynch D.H., Leibson P., Paya C.V. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:1997;55-64.
80. de Oliveira Pinto L.M., Garcia S., Lecoeur H., Rapp C., Gougeon M.L. Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood. 99:2002;1666-1675.
81. Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W.A., Verdin E. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature. 395:1998;189-194.
82. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
83. D. Arnoult, F. Petit, J.D. Lelievre, D. Lecossier, A.J. Hance, V. Monceaux, R. Ho Tsong Fang, B. Hurtrel, J.C. Ameisen, J. Estaquier, Caspase-dependent and -independent T cell death pathways in pathogenic Simian Immunodeficiency Virus infection. Relationship with disease evolution (submitted).
84. Badley A.D., Parato K., Cameron D.W., Kravcik S., Phenix B.N., Ashby D., Kumar A., Lynch D.H., Tschopp J., Angel J.B. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ. 6:1999;420-432.
85. Herbein G., Van Lint C., Lovett J.L., Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72:1998;660-670.
86. Chirmule N., Pahwa S. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60:1996;386-406.
87. Wang Z.Q., Dudhane A., Orlikowsky T., Clarke K., Li X., Darzynkiewicz Z., Hoffmann M.K. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24:1994;1549-1552.
88. Finco O., Nuti S., De Magistris M.T., Mangiavacchi L., Aiuti A., Forte P., Fantoni A., van der Putten H., Abrignani S. Induction of CD4+ T cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur. J. Immunol. 27:1997;1319-1324.
89. Vlahakis S.R., Algeciras-Schimnich A., Bou G., Heppelmann C.J., Villasis-Keever A., Collman R.C., Paya C.V. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J. Clin. Invest. 107:2001;207-215.
90. Desbarats J., Freed J.H., Campbell P.A., Newell M.K. Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells. Proc. Natl. Acad. Sci. USA. 93:1996;11014-11018.
91. Oyaizu N., McCloskey T.W., Than S., Hu R., Kalyanaraman V.S., Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood. 84:1994;2622-2631.
92. Tateyama M., Oyaizu N., McCloskey T.W., Than S., Pahwa S. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood. 96:2000;195-202.
93. Somma F., Tuosto L., Montani M.S., Di Somma M.M., Cundari E., Piccolella E. Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis. J. Immunol. 164:2000;5078-5087.
94. Hashimoto F., Oyaizu N., Kalyanaraman V.S., Pahwa S. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood. 90:1997;745-753.
95. Petit F., Corbeil J., Lelievre J.D., Parseval L.M., Pinon G., Green D.R., Ameisen J.C., Estaquier J. Role of CD95-activated caspase-1 processing of IL-1β in TCR-mediated proliferation of HIV-infected CD4(+) T cells. Eur. J. Immunol. 31:2001;3513-3524.
96. Estaquier J., Lelievre J.D., Petit F., Brunner T., Moutouh-De Parseval L., Richman D.D., Ameisen J.C., Corbeil J. Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. J. Virol. 76:2002;5966-5973.
97. Orlikowsky T., Wang Z.Q., Dudhane A., Horowitz H., Riethmuller G., Hoffmann M.K. Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion. AIDS Res. Hum. Retroviruses. 13:1997;953-960.
98. Ohnimus H., Heinkelein M., Jassoy C. Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J. Immunol. 159:1997;5246-5252.
99. Katsikis P.D., Garcia-Ojeda M.E., Wunderlich E.S., Smith C.A., Yagita H., Okumura K., Kayagaki N., Alderson M., Herzenberg L.A. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 8:1996;1311-1317.
100. McCloskey T.W., Bakshi S., Than S., Arman P., Pahwa S. Immunophenotypic analysis of peripheral blood mononuclear cells undergoing in vitro apoptosis after isolation from human immunodeficiency virus-infected children. Blood. 92:1998;4230-4237.
101. Miura Y., Misawa N., Maeda N., Inagaki Y., Tanaka Y., Ito M., Kayagaki N., Yamamoto N., Yagita H., Mizusawa H., Koyanagi Y. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J. Exp. Med. 193:2001;651-660.
102. Lecossier D., Bouchonnet F., Schneider P., Clavel F., Hance A.J. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. J. Infect. Dis. 183:2001;1009-1016.
103. Dragic T., Charneau P., Clavel F., Alizon M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66:1992;4794-4802.
104. Lifson J.D., Reyes G.R., McGrath M.S., Stein B.S., Engleman E.G. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science. 232:1986;1123-1127.
105. Sodroski J., Goh W.C., Rosen C., Campbell K., Haseltine W.A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature. 322:1986;470-474.
106. Banda N.K., Bernier J., Kurahara D.K., Kurrle R., Haigwood N., Sekaly R.P., Finkel T.H. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1992;1099-1106.
107. Briand G., Barbeau B., Corbeil J., Tremblay M. Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56lck. Virology. 231:1997;10-19.
108. Shi L., Nishioka W.K., Th'ng J., Bradbury E.M., Litchfield D.W., Greenberg A.H. Premature p34cdc2 activation required for apoptosis. Science. 263:1994;1143-1145.
109. Piedimonte G., Corsi D., Paiardini M., Cannavo G., Ientile R., Picerno I., Montroni M., Silvestri G., Magnani M. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients. AIDS. 13:1999;1159-1164.
110. Cannavo G., Paiardini M., Galati D., Cervasi B., Montroni M., De Vico G., Guetard D., Bocchino M.L., Picerno I., Magnani M., Silvestri G., Piedimonte G. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis. Blood. 97:2001;1756-1764.
111. Castedo M., Roumier T., Blanco J., Ferri K.F., Barretina J., Tintignac L.A., Andreau K., Perfettini J.L., Amendola A., Nardacci R., Leduc P., Ingber D.E., Druillennec S., Roques B., Leibovitch S.A., Vilella-Bach M., Chen J., Este J.A., Modjtahedi N., Piacentini M., Kroemer G. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J. 21:2002;4070-4080.
112. Castedo M., Ferri K.F., Blanco J., Roumier T., Larochette N., Barretina J., Amendola A., Nardacci R., Metivier D., Este J.A., Piacentini M., Kroemer G. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J. Exp. Med. 194:2001;1097-1110.
113. Levy D.N., Refaeli Y., MacGregor R.R., Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:1994;10873-10877.
114. Stewart S.A., Poon B., Jowett J.B., Chen I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:1997;5579-5592.
115. Jacotot E., Ravagnan L., Loeffler M., Ferri K.F., Vieira H.L., Zamzami N., Costantini P., Druillennec S., Hoebeke J., Briand J.P., Irinopoulou T., Daugas E., Susin S.A., Cointe D., Xie Z.H., Reed J.C., Roques B.P., Kroemer G. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191:2000;33-46.
116. Yao X.J., Mouland A.J., Subbramanian R.A., Forget J., Rougeau N., Bergeron D., Cohen E.A. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol. 72:1998;4686-4693.
117. Piller S.C., Jans P., Gage P.W., Jans D.A. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc. Natl. Acad. Sci. USA. 95:1998;4595-4600.
118. Shostak L.D., Ludlow J., Fisk J., Pursell S., Rimel B.J., Nguyen D., Rosenblatt J.D., Planelles V. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp. Cell Res. 251:1999;156-165.
119. Poon B., Grovit-Ferbas K., Stewart S.A., Chen I.S. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science. 281:1998;266-269.
120. Hrimech M., Yao X.J., Bachand F., Rougeau N., Cohen E.A. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 73:1999;4101-4109.
121. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
122. Jacotot E., Ferri K.F., El Hamel C., Brenner C., Druillennec S., Hoebeke J., Rustin P., Metivier D., Lenoir C., Geuskens M., Vieira H.L., Loeffler M., Belzacq A.S., Briand J.P., Zamzami N., Edelman L., Xie Z.H., Reed J.C., Roques B.P., Kroemer G. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J. Exp. Med. 193:2001;509-519.
123. Schuler W., Wecker K., de Rocquigny H., Baudat Y., Sire J., Roques B.P. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J. Mol. Biol. 285:1999;2105-2117.
124. Vieira H.L., Haouzi D., El Hamel C., Jacotot E., Belzacq A.S., Brenner C., Kroemer G. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ. 7:2000;1146-1154.
125. Roumier T., Vieira H.L., Castedo M., Ferri K.F., Boya P., Andreau K., Druillennec S., Joza N., Penninger J.M., Roques B., Kroemer G. The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ. 9:2002;1212-1219.
126. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;935-944.
127. Levy D.N., Fernandes L.S., Williams W.V., Weiner D.B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 72:1993;541-550.
128. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1995;1243-1252.
129. Gervaix A., West D., Leoni L.M., Richman D.D., Wong-Staal F., Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA. 94:1997;4653-4658.
130. J.D. Lelievre, F. Mammano, D. Arnoult, F. Petit, A. Grodet, J. Estaquier, J.C. Ameisen, Neighboring dying cells drive the capacity of HIV1 to induce death of noncycling primary CD4+ T lymphocytes: a potential amplification loop in AIDS pathogenesis (submitted).
131. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3:1997;1117-1123.
132. Fukumori T., Akari H., Iida S., Hata S., Kagawa S., Aida Y., Koyama A.H., Adachi A. The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett. 432:1998;17-20.
133. Macreadie I.G., Thorburn D.R., Kirby D.M., Castelli L.A., de Rozario N.L., Azad A.A. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae. FEBS Lett. 410:1997;145-149.
134. Matarrese P., Conti L., Varano B., Gauzzi M.C., Belardelli F., Gessani S., Malorni W. The HIV-1 vpr protein induces anoikis-resistance by modulating cell adhesion process and microfilament system assembly. Cell Death Differ. 7:2000;25-36.
135. Conti L., Rainaldi G., Matarrese P., Varano B., Rivabene R., Columba S., Sato A., Belardelli F., Malorni W., Gessani S. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J. Exp. Med. 187:1998;403-413.
136. Rapaport E., Casella C.R., Iklé D., Mustafa F., Isaak D., Finkel T.H. Mapping of HIV-1 determinants of apoptosis in infected T cells. Virology. 252:1998;407-417.
137. Li C.J., Friedman D.J., Wang C., Metelev V., Pardee A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 268:1995;429-431.
138. Li-Weber M., Laur O., Dern K., Krammer P.H. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-κB. Eur. J. Immunol. 30:2000;661-670.
139. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
140. Bartz S.R., Emerman M. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J. Virol. 73:1999;1956-1963.
141. Sastry K.J., Marin M.C., Nehete P.N., McConnell K., el-Naggar A.K., McDonnell T.J. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene. 13:1996;487-493.
142. Westendorp M.O., Shatrov V.A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P.H., Droge W., Lehmann V. HIV-1 Tat potentiates TNF-induced
143. Ehret A., Westendorp M.O., Herr I., Debatin K.M., Heeney J.L., Frank R., Krammer P.H. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J. Virol. 70:1996;6502-6507.
144. Creaven M., Hans F., Mutskov V., Col E., Caron C., Dimitrov S., Khochbin S. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry. 38:1999;8826-8830.
145. Chen D., Wang M., Zhou S., Zhou Q. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J. 21:2002;6801-6810.
146. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
147. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:2002;759-767.
148. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
149. McCloskey T.W., Ott M., Tribble E., Khan S.A., Teichberg S., Paul M.O., Pahwa S., Verdin E., Chirmule N. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1997;1014-1019.
150. Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., La Placa M., Capitani S. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:1993;4481-4485.
151. Zauli G., Gibellini D., Caputo A., Bassini A., Negrini M., Monne M., Mazzoni M., Capitani S. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood. 86:1995;3823-3834.
152. Hammer S.M., Squires K.E., Hughes M.D., Grimes J.M., Demeter L.M., Currier J.S., Eron J.J. Jr., Feinberg J.E., Balfour H.H. Jr., Deyton L.R., Chodakewitz J.A., Fischl M.A. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337:1997;725-733.
153. Gulick R.M., Mellors J.W., Havlir D., Eron J.J., Gonzalez C., McMahon D., Richman D.D., Valentine F.T., Jonas L., Meibohm A., Emini E.A., Chodakewitz J.A. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:1997;734-739.
154. Collier A.C., Coombs R.W., Schoenfeld D.A., Bassett R.L., Timpone J., Baruch A., Jones M., Facey K., Whitacre C., McAuliffe V.J., Friedman H.M., Merigan T.C., Reichman R.C., Hooper C., Corey L. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N. Engl. J. Med. 334:1996;1011-1017.
155. Johnson N., Parkin J.M. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin. Exp. Immunol. 113:1998;229-234.
156. Kotler D.P., Shimada T., Snow G., Winson G., Chen W., Zhao M., Inada Y., Clayton F. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS. 12:1998;597-604.
157. Konvalinka J., Litterst M.A., Welker R., Kottler H., Rippmann F., Heuser A.M., Krausslich H.G. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69:1995;7180-7186.
158. Adams L.D., Tomasselli A.G., Robbins P., Moss B., Heinrikson R.L. HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res. Hum. Retroviruses. 8:1992;291-295.
159. Buttner J., Dornmair K., Schramm H.J. Screening of inhibitors of HIV-1 protease using an Escherichia coli cell assay. Biochem. Biophys. Res. Commun. 233:1997;36-38.
160. Riviere Y., Blank V., Kourilsky P., Israel A. Processing of the precursor of NF-κB by the HIV-1 protease during acute infection. Nature. 350:1991;625-626.
161. Nie Z., Phenix B.N., Lum J.J., Alam A., Lynch D.H., Beckett B., Krammer P.H., Sekaly R.P., Badley A.D. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ. 9:2002;1172-1184.
162. Andre P., Groettrup M., Klenerman P., de Giuli R., Booth B.L. Jr., Cerundolo V., Bonneville M., Jotereau F., Zinkernagel R.M., Lotteau V. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA. 95:1998;13120-13124.
163. Sloand E.M., Maciejewski J., Kumar P., Kim S., Chaudhuri A., Young N. Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells. Blood. 96:2000;2735-2739.
164. Sloand E.M., Kumar P.N., Kim S., Chaudhuri A., Weichold F.F., Young N.S. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood. 94:1999;1021-1027.
165. Phenix B.N., Angel J.B., Mandy F., Kravcik S., Parato K., Chambers K.A., Gallicano K., Hawley-Foss N., Cassol S., Cameron D.W., Badley A.D. Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res. Hum. Retroviruses. 16:2000;559-567.
166. Phenix B.N., Lum J.J., Nie Z., Sanchez-Dardon J., Badley A.D. Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood. 98:2001;1078-1085.
167. Lewis W., Copeland W.C., Day B.J. Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab. Invest. 81:2001;777-790.
168. Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322:1990;1098-1105.
169. Lamperth L., Dalakas M.C., Dagani F., Anderson J., Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65:1991;742-751.
170. Pezeshkpour G., Illa I., Dalakas M.C. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum. Pathol. 22:1991;1281-1288.
171. Lewis W., Papoian T., Gonzalez B., Louie H., Kelly D.P., Payne R.M., Grody W.W. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Invest. 65:1991;228-236.
172. Lewis W., Dalakas M.C. Mitochondrial toxicity of antiviral drugs. Nat. Med. 1:1995;417-422.
173. Groopman J.E. Zidovudine intolerance. Rev. Infect. Dis. 12(Suppl. 5):1990;S500-S506.
174. Benveniste O., Estaquier J., Lelievre J.D., Vilde J.L., Ameisen J.C., Leport C. Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo. Eur. J. Clin. Microbiol. Infect. Dis. 20:2001;896-897.
175. McQuade T.J., Tomasselli A.G., Liu L., Karacostas V., Moss B., Sawyer T.K., Heinrikson R.L., Tarpley W.G. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science. 247:1990;454-456.
176. Meek T.D., Lambert D.M., Dreyer G.B., Carr T.J., Tomaszek T.A. Jr., Moore M.L., Strickler J.E., Debouck C., Hyland L.J., Matthews T.J.et al. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature. 343:1990;90-92.
177. Pajonk F., Himmelsbach J., Riess K., Sommer A., McBride W.H. The human immunodeficiency virus (HIV-1) protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res. 62:2002;5230-5235.
178. Gaedicke S., Firat-Geier E., Constantiniu O., Lucchiari-Hartz M., Freudenberg M., Galanos C., Niedermann G. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis. Cancer Res. 62:2002;6901-6908.
179. van Heeswijk R.P., Veldkamp A.I., Mulder J.W., Meenhorst P.L., Lange J.M., Beijnen J.H., Hoetelmans R.M. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study. AIDS. 14:2000;F103-F110.
180. Stein D.S., Fish D.G., Bilello J.A., Preston S.L., Martineau G.L., Drusano G.L. A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS. 10:1996;485-492.
181. Merry C., Barry M.G., Mulcahy F., Ryan M., Heavey J., Tjia J.F., Gibbons S.E., Breckenridge A.M., Back D.J. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS. 11:1997;F29-33.
182. Hsu A., Granneman G.R., Cao G., Carothers L., Japour A., El-Shourbagy T., Dennis S., Berg J., Erdman K., Leonard J.M., Sun E. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrob. Agents Chemother. 42:1998;2784-2791.
183. van Heeswijk R.P., Veldkamp A.I., Hoetelmans R.M., Mulder J.W., Schreij G., Hsu A., Lange J.M., Beijnen J.H., Meenhorst P.L. The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals. AIDS. 13:1999;F95-F99.
184. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 256:1992;628-632.
185. Wallace D.C., Shoffner J.M., Watts R.L., Juncos J.L., Torroni A. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 32:1992;113-114.
186. Estaquier J., Peeters M., Bedjabaga L., Honore C., Bussi P., Dixson A., Delaporte E. Prevalence and transmission of simian immunodeficiency virus and simian T-cell leukemia virus in a semi-free-range breeding colony of mandrills in Gabon. AIDS. 5:1991;1385-1386.
187. Onanga R., Kornfeld C., Pandrea I., Estaquier J., Souquiere S., Rouquet P., Mavoungou V.P., Bourry O., M'Boup S., Barre-Sinoussi F., Simon F., Apetrei C., Roques P., Muller-Trutwin M.C. High levels of viral replication contrast with only transient changes in CD4 (+) and CD8 (+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx. J. Virol. 76:2002;10256-10263.
188. Diop O.M., Gueye A., Dias-Tavares M., Kornfeld C., Faye A., Ave P., Huerre M., Corbet S., Barre-Sinoussi F., Muller-Trutwin M.C. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J. Virol. 74:2000;7538-7547.
189. Peeters M., Honore C., Huet T., Bedjabaga L., Ossari S., Bussi P., Cooper R.W., Delaporte E. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS. 3:1989;625-630.
190. Peeters M., Janssens W., Fransen K., Brandful J., Heyndrickx L., Koffi K., Delaporte E., Piot P., Gershy-Damet G.M., van der Groen G. Isolation of simian immunodeficiency viruses from two sooty mangabeys in Cote d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res. Hum. Retroviruses. 10:1994;1289-1294.